Avi Dukler

Avi Dukler is an accomplished professional with extensive experience in the biotechnology and healthcare sectors. Currently serving as a Venture Partner at CANCER FUND since August 2023, Avi is focused on investing in cancer innovations to enhance patient outcomes and reduce healthcare costs. As Managing Partner at AAD Health - Go-To-Market Diagnostics since October 2013, Avi has been instrumental in simplifying product launch processes by integrating strategy, clinical operations, regulation, and reimbursement. Prior roles include Fractional CEO at Kepler Diagnostics, Inc. from December 2015 to October 2022, where the company contributed to global health advancements through accessible specimen collection devices, and President & CEO of Glycominds from January 1999 to September 2013, overseeing a publicly traded biotechnology firm. Avi holds a Ph.D. in Biotechnology and a Bachelor of Science in Life Sciences from Tel Aviv University, acquired between 1990 and 1998.